JMJair Meza

Jair Meza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jair Meza has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A data model for longitudinal multi-modal biomedical cohorts

    by Christian Ramirez, Ross W. Swofford, Alyssa Lima, Huong Phan, Nishigandha Phalke, Jonathan Fisher, Matthew C Lacadie, Jair Meza, Mansi Khandpekar, Zhiping Weng, et al.

    Longitudinal multimodal cohort studies require data models that can integrate heterogeneous molecular, phenotypic, and contextual data while preserving relationships across participants, biospecimens, study visits, and computational transformations. Here, we present the data model developed for the Multi-Omics for Health and Disease (MOHD) Consortium, a modality-agnostic, provenance-driven framework designed to support an evolving longitudinal biomedical resource. The model uses a compact set of linked entities and a central dataset abstraction to represent experimental, phenotypic and contextual, and computational data within a common framework. Stable identifiers, explicit provenance relationships, and flexible grouping structures enable data to be tracked across biological sources, processing workflows, and releases without requiring modality-specific restructuring of the core model. To address the complexity of participant context, we developed a harmonization framework that transforms branched REDCap survey data into a longitudinal, machine-readable representation with normalized variables and explicit response status. Interoperability with external data models and ontologies is supported through reproducible translation workflows while maintaining a stable canonical representation. We demonstrate the model through its implementation in the first production-scale MOHD data release, encompassing 956 participants, nearly 7,000 datasets, and more than 40,000 files across multiple molecular modalities and study visits. This implementation demonstrates the ability of the model to accommodate heterogeneous and longitudinal data, evolving computational products, participant withdrawal, and distinct data-access environments. Together, the MOHD implementation provides a practical framework and generalizable design principles for building longitudinal multimodal biomedical resources that remain traceable, interoperable, and adaptable as data and analytical requirements evolve.

  • Open Access

    An Expanded Registry of Candidate cis-Regulatory Elements for Studying Transcriptional Regulation

    by Jill E. Moore, Henry E. Pratt, Kaili Fan, Nishigandha Phalke, Jonathan Fisher, Shaimae I. Elhajjajy, Gregory Andrews, Mingshi Gao, Nicole Shedd, Yu Fu, et al.

    Mammalian genomes contain millions of regulatory elements that control the complex patterns of gene expression. Previously, The ENCODE consortium mapped biochemical signals across many cell types and tissues and integrated these data to develop a Registry of 0.9 million human and 300 thousand mouse candidate cis-Regulatory Elements (cCREs) annotated with potential functions 1 . We have expanded the Registry to include 2.35 million human and 927 thousand mouse cCREs, leveraging new ENCODE datasets and enhanced computational methods. This expanded Registry covers hundreds of unique cell and tissue types, providing a comprehensive understanding of gene regulation. Functional characterization data from assays like STARR-seq, MPRA, CRISPR perturbation, and transgenic mouse assays now cover over 90% of human cCREs, revealing complex regulatory functions. We identified thousands of novel silencer cCREs and demonstrated their dual enhancer/silencer roles in different cellular contexts. Integrating the Registry with other ENCODE annotations facilitates genetic variation interpretation and trait-associated gene identification, exemplified by discovering KLF1 as a novel causal gene for red blood cell traits. This expanded Registry is a valuable resource for studying the regulatory genome and its impact on health and disease.